Study Links Diabetes Drug Glipizide To Increased Cardiovascular Risk
A new study conducted by researchers at Mass General Brigham has raised concerns over Glipizide, a widely used sulfonylurea for type 2 diabetes.
Silent Killer Hypertension Hits 294 Million In Southeast Asia; Warns WHO
WHO has warned that hypertension affects more than 294 million people across Southeast Asia, India accounting for over 220 million cases.
